COMMONWEALTH EQUITY SERVICES, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 62 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$8,000
-20.0%
11,0000.0%0.00%
Q2 2022$10,0000.0%11,0000.0%0.00%
Q1 2022$10,0000.0%11,0000.0%0.00%
Q4 2021$10,0000.0%11,0000.0%0.00%
Q3 2021$10,0000.0%11,0000.0%0.00%
Q2 2021$10,0000.0%11,0000.0%0.00%
Q1 2021$10,0000.0%11,0000.0%0.00%
Q4 2020$10,0000.0%11,0000.0%0.00%
Q3 2020$10,0000.0%11,0000.0%0.00%
Q2 2020$10,0000.0%11,0000.0%0.00%
Q1 2020$10,0000.0%11,0000.0%0.00%
Q4 2019$10,000
+11.1%
11,0000.0%0.00%
Q3 2019$9,000
-10.0%
11,0000.0%0.00%
Q2 2019$10,0000.0%11,0000.0%0.00%
Q1 2019$10,000
+11.1%
11,0000.0%0.00%
Q4 2018$9,000
-10.0%
11,0000.0%0.00%
Q3 2018$10,000
-37.5%
11,000
-35.3%
0.00%
Q2 2018$16,000
+14.3%
17,0000.0%0.00%
Q1 2018$14,000
-6.7%
17,0000.0%0.00%
Q4 2017$15,00017,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2017
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 95,823,000$114,365,0005.28%
INCOME RESEARCH & MANAGEMENT 12,056,000$14,384,0002.34%
AEGON USA Investment Management, LLC 6,000,000$7,159,0001.44%
MACKAY SHIELDS LLC 18,832,000$22,547,0001.02%
CSS LLC/IL 14,850,000$17,728,0000.86%
SHENKMAN CAPITAL MANAGEMENT INC 8,492,000$10,174,0000.78%
ADVENT CAPITAL MANAGEMENT /DE/ 33,022,000$39,393,0000.57%
PALISADE CAPITAL MANAGEMENT, LP 6,088,000$7,254,0000.26%
AXA S.A. 34,000,000$40,566,0000.18%
SSI INVESTMENT MANAGEMENT LLC 1,664,000$1,975,0000.18%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders